Want to join the conversation?
$SYF said its return on assets was 2.4% and return on equity was 14.6% in 2Q16. Net interest margin increased 9 BPs to 15.86%. The company's efficiency ratio was 31.9%, a 157 BP improvement from 2Q15, driven by positive operating leverage arising from strong revenue growth that exceeded expense growth.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.